In line with Expectation: 3QFY16 core PATAMI (excluding RM85m fair value gain on investment properties and RM71m gain on purchase for land acquisition in IOI Resort City) increased 4% YoY, bringing 9MFY16 core PATAMI to RM402m, accounting for 73% of ours and consensus full year earnings forecast.
Highlights
9MFY16 revenue surged by 65% YoY on the back of improvement from all its business segments. Property development increased by 72% YoY mainly contributed by Triling project in Singapore and IOI Palm City in Xiamen.
New property sales in 3QFY16 achieved RM402m (versus RM390m in 3QFY15), with 50% from Malaysia, 31% from China and 19% from Singapore. 9MFY16 sales achieved RM1.46bn, on track to exceed RM1.7bn sales target for the year.
With the strong recovery in China’s property market, the take up rate for Phase 2 for IOI Palm City is more than 90%. The remaining GDV for IOI Palm City is about RMB3.5bn which will sustain its sales for next 2- 3 years. The company is planning to launch its 3th phase in 4QFY16.
Unbilled has also increased from RM1.4bn to RM1.5bn, representing about 1x of FY15 property development revenue.
In 3QFY16, operating profit from property investment surged by 74% YoY, contributed by IOI City Mall, Putrajaya which enjoy more than 90% occupancy. The company aims to increase its investment properties income from 15% of total income to 30-40% in future.
IOIProp is one of the value stocks in our universe coverage given it is only trading at 0.63x FY17 P/B as compare to peer at average 1x. We believe the stock warrants a re-rating given its strong track record in township development and its attractive valuation.
Rating
BUY
Positives: highly liquid proxy to property sector; large war-chest for landbank acquisitions; has exposure to Singapore and China property markets; enjoys vast and cheap landbank.
Negatives: Could face sector headwinds in Malaysia, while the Singapore and China property markets are also currently at the low point of their cycles.
Valuation
TP remained unchanged at RM2.77 based on unchanged 35% discount to RNAV. Maintain BUY.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....